Health Imaging: New guide helps clinicians better diagnose coronary artery disease using PET myocardial blood flow

Two of molecular imaging’s top professional organizations published new guidelines for using positron emission tomography to better diagnose coronary artery disease.

Measuring myocardial blood flow as part of perfusion imaging has been a key development in the field and should be part of providers’ daily workflow, experts said in a statement.

“While there are many excellent publications on all aspects of PET blood flow quantification, we felt that there existed a gap, especially for nuclear physicians practicing in non-academic centers,” said Dr. Timothy Bateman, cardiologist at Saint Luke's Mid America Heart Institute and a lead author of the writing committee composed of world-renowned leaders in cardiac PET.

Read the full Health Imaging article: New guide helps clinicians better diagnose coronary artery disease using PET myocardial blood flow

Related Content

Reuters
Mar. 25, 2021

Reuters Health: Diuretic effect may not mediate most empagliflozin benefits in heart-failure patients
Reuters Health talked to Dr. Mikhail Kosiborod about what a new study's findings mean for patients with reduced ejection fraction and clinical practice moving forward.
Oct. 27, 2020

U.S. News & World Report: MRIs might be safe for patients with implanted heart devices
Dr. Sanjaya Gupta explains the findings of the recent study and what this means for patients moving forward.
""
Sep. 14, 2020

New Clinical Trial for Heart Failure Tests Patients Remotely Using Wearable Devices
The world's first decentralized, digitally driven medical study has patients wear smart watches to record the effects of a heart failure medication.